An excerpt from Narrative Medicine in the Age of Uncertainty: When Systems Strain and Stories Steady.
When a nonprofit hospital system posts a $201 million operating loss, lays off roughly 650 workers, and then buys naming rights to an NFL practice facility, it does not just create bad optics. It teaches a lesson.
Not to the marketing department. To the workforce.
In Philadelphia, Jefferson Health reported a $201 million operating loss in the first half of fiscal 2026, including restructuring charges tied to layoffs affecting roughly 600 to 700 employees. Days later, the Philadelphia Eagles announced that the team’s long-known NovaCare Complex would be renamed the Jefferson Health Training Complex as part of an expanded partnership.
If you are a nurse manager trying to cover shifts after positions were eliminated, or a clinic administrator told to “do more with less,” the rebrand reads less like civic pride and more like a hierarchy of values.
You can call it strategy. Staff will call it a tell.
The moment “mission” stops sounding like a mission
In comment threads and break rooms alike, the reaction was strikingly consistent: a disconnect between nonprofit mission language and nonprofit spending choices.
Some clinicians described the deal as “marketing theater,” signaling that branding had been prioritized over operational stability. Others asked the obvious question: Is not tax-exempt status supposed to mean reinvesting in the community? A patient advocate put it more bluntly: When people are lying in a hospital bed worrying about their health and their bills, nobody cares about brand.
A nonprofit executive countered with a familiar refrain: If the spending is legal under 501(c)(3) rules, then the problem lies with the law, not with the institution.
That argument is not wrong. It is just incomplete.
What is legal can still be damaging. And what is demoralizing, repeated at scale, becomes culture.
The nonprofit paradox: tax-exempt, market-driven
Nonprofit health systems operate in competitive markets. They advertise, acquire, rebrand, and pursue growth, all while benefiting from tax exemption justified by community benefit and public mission.
In a pure market-share framing, a sports partnership is rational. The Eagles are a regional identity engine. Brand association can translate into patient preference, employer contracting leverage, philanthropic visibility, recruitment appeal, and downstream revenue.
The ethical tension is not that a system wants to be known.
It is the sequencing.
Layoffs are framed as necessity, “significant financial headwinds.” The language suggests weather, not decisions. It implies inevitability, like a storm.
Then comes a high-profile naming-rights deal, and the workforce is expected to accept that both actions emerged from the same ledger of scarcity.
This is where trust fractures, not because staff do not understand branding, but because they understand budgets.
Leaders can argue that marketing and labor reside in different buckets. They can say workforce reductions ensure sustainability while brand investments drive future growth. They can note that certain funds are restricted or sourced differently.
All plausible. None emotionally persuasive when colleagues just lost their jobs.
What clinicians hear when the system says, “We had to.”
Health care leaders often underestimate how closely frontline staff read institutional behavior. Culture is not defined in town halls; it is inferred from what gets protected when times are hard.
A naming-rights announcement after layoffs reframes the past year:
- The “efficiency” campaign feels less about efficiency and more about power.
- The “mission” messaging sounds more like optics.
- The “hard choices” appear downstream, not shared.
Once that reframing takes hold, it spreads. It becomes part of the informal curriculum trainees absorb. It shapes how burned-out physicians talk to medical students. It fuels the quiet cynicism that turns retention slogans into punchlines.
Board governance rarely enters these conversations, but it should. Boards approve strategy. They authorize executive compensation. They sanction branding investments.
Boards do not round on units. They do not staff call centers. They do not explain delays to anxious families.
But boards approve the decisions that shape those experiences.
Beyond one deal
It is tempting to treat this as a single controversy with a single villain: nonprofit “theater.” But focusing on outrage misses the larger pattern.
Jefferson is not unique in pursuing high-visibility sports partnerships. Across markets, nonprofit systems seek consumer attention and competitive positioning while simultaneously claiming fragility when it comes to staffing.
In that environment, “mission” risks becoming a slogan, unless it is anchored by enforceable expectations.
The real question is not whether marketing is allowed.
It is what accountability looks like when tax-exempt institutions behave like corporate conglomerates.
From feelings to guardrails
If current law permits these decisions, then reform must be structural. “Change the laws” cannot remain a rhetorical shrug.
Several guardrails could increase accountability without micromanaging hospitals:
- First, transparency triggers. When a tax-exempt health system conducts workforce reductions above a defined threshold, require public disclosure of major marketing or branding commitments made within a specified time window, including contract ranges. Transparency does not prohibit strategy; it clarifies priorities.
- Second, stronger community benefit standards. Current definitions are broad and easily satisfied. Policymakers could define measurable thresholds tied to access, affordability, and workforce stability, metrics that reflect lived community impact rather than accounting categories.
- Third, board accountability disclosures. Require governing boards of tax-exempt systems to formally attest, annually, that major branding expenditures align with mission and do not materially impair staffing, access, or safety. Accountability often begins as paperwork before it becomes culture.
- Fourth, more active state charity oversight. States already oversee nonprofit entities. Attorneys general could be empowered to review whether patterns of spending and labor practices remain consistent with public benefit obligations when concerns arise.
None of these proposals ban marketing. They simply reject the idea that “nonprofit” is a moral halo rather than a regulated status with reciprocal obligations.
The headline is not the Eagles. It is the workforce.
The Eagles will still practice. Fans will adjust to the new name. The signage will look sharp. Cameras will pan. And I will still bleed green for my beloved Birds.
But inside the health system, the name on the building is not the point.
The point is that health care workers are being asked, again, to absorb the costs of “financial headwinds” while leadership invests in visibility. When that happens, mission language begins to sound like branding copy.
And once clinicians conclude they work for a brand rather than a mission, their behavior changes. They detach. They leave. They stop believing that sacrifice is shared.
That is not a public relations problem.
It is a system integrity problem.
Nonprofit health care depends on public trust and internal morale. When either erodes, tax status and naming rights offer little insulation. What sustains institutions over time is not the size of their logo on a stadium wall, but the credibility of their commitments when resources are scarce.
In health care, sequencing matters. So does symbolism.
If nonprofit systems want to preserve the moral authority embedded in their status, they must ensure that when hard choices are made, they are experienced as shared sacrifice, not as branding opportunity.
Otherwise, the lesson being taught will not be about growth or strategy.
It will be about what the institution truly values.
Arthur Lazarus is a former Doximity Fellow, a member of the editorial board of the American Association for Physician Leadership, and an adjunct professor of psychiatry at the Lewis Katz School of Medicine at Temple University in Philadelphia. He is the author of several books on narrative medicine and the fictional series Real Medicine, Unreal Stories. His latest book, a novel, is JAILBREAK: When Artificial Intelligence Breaks Medicine.
